 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 01/12/2026 |
$10.34 |
$10.49 |
$10.00 |
$10.29 |
791.60K | | 01/13/2026 |
$10.29 |
$10.49 |
$10.15 |
$10.42 |
380.80K | | 01/14/2026 |
$10.36 |
$10.46 |
$10.17 |
$10.38 |
337.20K | | 01/15/2026 |
$10.38 |
$10.39 |
$10.06 |
$10.21 |
449.60K | | 01/16/2026 |
$10.21 |
$10.64 |
$10.08 |
$10.37 |
537.80K |
|
|
| Delcath Systems is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. Co.'s primary product candidate, the HEPZATO™ KIT (melphalan hydrochloride for injection/hepatic delivery system) (HEPZATO), is a drug/device combination product. HEPZATO is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. In Europe, Co.'s commercial product is a stand-alone medical device having the same device components as the HEZPATO but without the melphalan hydrochloride and is approved for sale under the trade name CHEMOSAT® Hepatic Delivery System for Melphalan. | |
|
Delcath Systems (DCTH) has the following price history information. Looking back at DCTH historical stock prices for the last five trading days, on January 12, 2026, DCTH opened at $10.34, traded as high as $10.49 and as low as $10.00, and closed at $10.29. Trading volume was a total of 791.60K shares. On January 13, 2026, DCTH opened at $10.29, traded as high as $10.49 and as low as $10.15, and closed at $10.42. Trading volume was a total of 380.80K shares. On January 14, 2026, DCTH opened at $10.36, traded as high as $10.46 and as low as $10.17, and closed at $10.38. Trading volume was a total of 337.20K shares. On January 15, 2026, DCTH opened at $10.38, traded as high as $10.39 and as low as $10.06, and closed at $10.21. Trading volume was a total of 449.60K shares. On January 16, 2026, DCTH opened at $10.21, traded as high as $10.64 and as low as $10.08, and closed at $10.37. Trading volume was a total of 537.80K shares.
DCTH Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Delcath Systems shares, starting with a $10,000 purchase of DCTH, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
05/03/2018 |
|
| End date: |
01/16/2026 |
|
| Start price/share: |
$1.35 |
|
| End price/share: |
$10.37 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
668.15% |
|
| Average Annual Total Return: |
30.26% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$76,817.60 |
|
| Years: |
7.71 |
|
|
|
| Date |
Close |
| 01/12/2026 | $10.29 | | 01/13/2026 | $10.42 | | 01/14/2026 | $10.38 | | 01/15/2026 | $10.21 | | 01/16/2026 | $10.37 |
|
|
Free DCTH Email Alerts:
